Skip to Main Content

Paper Details

Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.
Proc Natl Acad Sci U S A
90
2013
ALK, Foretinib, G2032R, GSK1363089, PF-02341066, ROS, ROS1, ROS1 kinase domain, ROS1(G2032R) mutant, cholangiocarcinoma, crizotinib, foretinib, glioblastoma, lung adenocarcinoma, lung cancer, multiple cancers, oncogenic ROS1 fusion proteins, patients, tumor
Author NameAffiliation
Monika A DavareKnight Cancer Institute, Howard Hughes Medical Institute, Oregon Health and Sciences University
Monika A DavareKnight Cancer Institute, Howard Hughes Medical Institute, Oregon Health and Sciences University
  • 1 - 2

Datasets

Release 1.2